Watson Strengthens its Presence in Australia and Southeast Asia with Acquisition of Strides Arcolab’s Ascent Pharmahealth
By Heather Cartwright
Pharma Deals Review: Vol 2012 Issue 2 (Table of Contents)
Published: 13 Feb-2012
DOI: 10.3833/pdr.v2012.i2.1683 ISSN: 1756-7874
Section: Mergers & Acquisitions
Fulltext:
Abstract
Watson Pharmaceuticals has strengthened its commercial presence in Australia and Southeast Asia by acquiring the Ascent Pharmahealth generic pharmaceutical business of India’s Strides Arcolab for AUS$375 M (US$394 M) in cash...
This page is available to subscribers only.
Not a subscriber? Join here
Already Registered? Please login using the top left purple box.
Copyright: © IQVIA 2018